Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 6 studies | 24% ± 7% | |
hematopoietic precursor cell | 4 studies | 21% ± 4% | |
epithelial cell | 4 studies | 28% ± 11% | |
dendritic cell | 3 studies | 33% ± 3% | |
intestinal crypt stem cell | 3 studies | 19% ± 4% | |
natural killer cell | 3 studies | 17% ± 1% |
Insufficient scRNA-seq data for expression of EXOSC5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 640.70 | 1445 / 1445 | 100% | 51.16 | 183 / 183 |
ovary | 100% | 630.42 | 180 / 180 | 100% | 92.64 | 430 / 430 |
uterus | 100% | 542.98 | 170 / 170 | 100% | 86.07 | 459 / 459 |
brain | 100% | 696.62 | 2635 / 2642 | 100% | 49.23 | 704 / 705 |
liver | 100% | 561.35 | 225 / 226 | 100% | 53.12 | 406 / 406 |
thymus | 100% | 494.43 | 652 / 653 | 100% | 51.85 | 603 / 605 |
pancreas | 100% | 755.67 | 328 / 328 | 99% | 46.67 | 177 / 178 |
intestine | 100% | 578.61 | 966 / 966 | 99% | 86.57 | 524 / 527 |
skin | 100% | 1019.12 | 1809 / 1809 | 99% | 80.79 | 469 / 472 |
stomach | 100% | 505.88 | 359 / 359 | 99% | 79.77 | 284 / 286 |
prostate | 100% | 568.24 | 245 / 245 | 99% | 58.92 | 498 / 502 |
bladder | 100% | 724.00 | 21 / 21 | 99% | 86.53 | 498 / 504 |
breast | 100% | 709.59 | 459 / 459 | 99% | 61.06 | 1104 / 1118 |
adrenal gland | 100% | 893.29 | 258 / 258 | 97% | 38.80 | 224 / 230 |
kidney | 100% | 439.11 | 89 / 89 | 97% | 43.93 | 877 / 901 |
lung | 93% | 378.30 | 537 / 578 | 98% | 60.15 | 1134 / 1155 |
adipose | 100% | 613.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 54.19 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 108.92 | 29 / 29 |
muscle | 100% | 1151.97 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 697.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 88.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 57.24 | 1 / 1 |
blood vessel | 100% | 484.37 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 420.84 | 826 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 753.95 | 832 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0006396 | Biological process | RNA processing |
GO_0034475 | Biological process | U4 snRNA 3'-end processing |
GO_0071051 | Biological process | poly(A)-dependent snoRNA 3'-end processing |
GO_0051607 | Biological process | defense response to virus |
GO_0006401 | Biological process | RNA catabolic process |
GO_0016075 | Biological process | rRNA catabolic process |
GO_0071028 | Biological process | nuclear mRNA surveillance |
GO_0000956 | Biological process | nuclear-transcribed mRNA catabolic process |
GO_0006364 | Biological process | rRNA processing |
GO_0045006 | Biological process | DNA deamination |
GO_0005730 | Cellular component | nucleolus |
GO_0000178 | Cellular component | exosome (RNase complex) |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000177 | Cellular component | cytoplasmic exosome (RNase complex) |
GO_0101019 | Cellular component | nucleolar exosome (RNase complex) |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000176 | Cellular component | nuclear exosome (RNase complex) |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0004532 | Molecular function | RNA exonuclease activity |
GO_0003723 | Molecular function | RNA binding |
GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
GO_0005515 | Molecular function | protein binding |
Gene name | EXOSC5 |
Protein name | Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B) Exosome component 5 |
Synonyms | CML28 RRP46 |
Description | FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes . In vitro, EXOSC5 does not bind or digest single-stranded RNA and binds to double-stranded DNA without detectable DNase activity . . |
Accessions | ENST00000221233.9 ENST00000596905.1 ENST00000602129.2 Q9NQT4 ENST00000593771.2 M0R102 M0R050 M0R289 |